source
- Amgen faces FTC-backed lawsuit over patent-application purchase amid insurer disputeAmgen and a large health insurer are locked in a court fight over whether purchasing a drug patent application can be used to extend a monopoly on a medicine. The case is drawing attention because…
- GLP-1 drugs push employers to rethink worker health-care costsGLP-1 medications are prompting many employers to reexamine how they fund employee health care. Rising prescription use and associated costs are forcing companies to consider new benefit designs an…